NFYS vs. PV, NETD, ENGN, RRAC, CDRO, IPXX, KAII, XPAX, PRPB, and LGVC
Should you be buying Enphys Acquisition stock or one of its competitors? The main competitors of Enphys Acquisition include Primavera Capital Acquisition (PV), Nabors Energy Transition Corp. II (NETD), enGene (ENGN), Rigel Resource Acquisition (RRAC), Codere Online Luxembourg (CDRO), Inflection Point Acquisition Corp. II (IPXX), Kismet Acquisition Two (KAII), Zalatoris II Acquisition (XPAX), CC Neuberger Principal Holdings II (PRPB), and LAMF Global Ventures Corp. I (LGVC).
Enphys Acquisition (NYSE:NFYS) and Primavera Capital Acquisition (NYSE:PV) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings.
In the previous week, Primavera Capital Acquisition had 1 more articles in the media than Enphys Acquisition. MarketBeat recorded 1 mentions for Primavera Capital Acquisition and 0 mentions for Enphys Acquisition. Enphys Acquisition's average media sentiment score of 0.00 equaled Primavera Capital Acquisition'saverage media sentiment score.
Primavera Capital Acquisition's return on equity of -60.73% beat Enphys Acquisition's return on equity.
Enphys Acquisition has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Primavera Capital Acquisition has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500.
50.9% of Enphys Acquisition shares are owned by institutional investors. Comparatively, 50.0% of Primavera Capital Acquisition shares are owned by institutional investors. 44.7% of Enphys Acquisition shares are owned by company insiders. Comparatively, 2.7% of Primavera Capital Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Enphys Acquisition and Primavera Capital Acquisition both received 0 outperform votes by MarketBeat users.
Summary
Enphys Acquisition and Primavera Capital Acquisition tied by winning 3 of the 6 factors compared between the two stocks.
Get Enphys Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for NFYS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NFYS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Enphys Acquisition Competitors List
Related Companies and Tools
